Doctor Bert Vandenberk

Doctor Bert Vandenberk

KU Leuven, Leuven (Belgium)

Member of:

Dr. Bert Vandenberk is an Assistant Professor in Cardiovascular Sciences at KU Leuven (BE) and a clinical cardiac electrophysiologist at UZ Leuven (BE). He pursued advanced studies at KU Leuven, completing a Ph.D. on ventricular arrhythmias and sudden cardiac death. His training included fellowships at UZ Leuven and the University of Calgary's Libin Cardiovascular Institute (CA). During these fellowships, he excelled in teaching, received recognition for excellence in teaching, and contributed significantly to academic publications. He completed the Global Clinical Scholars Research Training program at Harvard Medical School, earned the LB Mitchell Fellow Research Award for his outstanding contributions. Since returning to KU Leuven and UZ Leuven, he balances clinical practice with academia, focusing on catheter ablation and management of arrhythmias in patients with adult congenital heart disease.

Presentations

Syncope recurrence and long-term heart rate variability after cardioneuroablation for vasovagal syncope: a systematic review and meta-analysis

Event: ESC Congress 2022

Topic: Non-Device/Nonpharmacological Therapies (Tilt Training, Radiofrequency [RF] Ablation, etc.)

Session: Vasovagal syncope: new insights and improved interventions

Access

Repolarization abnormalities at admission predict 30-day outcome in COVID-19.

Event: EHRA 2021

Topic: Electrocardiography (ECG)

Session: New diagnostic methods in EP I

Access

Repeating non-invasive risk stratification tests improves the prediction of outcomes of ICD patients in the EUTrigTreat study.

Event: ESC Congress 2019

Topic: Risk Factors and Risk Assessment

Session: Implantable cardioverter defibrillator therapy

Access

QT correction and predictive value of QTc in atrial fibrillation

Event: EHRA EUROPACE - CARDIOSTIM 2017

Topic: ECG and arrhythmia analysis

Session: ECG and eCardiology

Access

Doctor Bert Vandenberk

Biography

Contributor content

Syncope recurrence and long-term heart rate variability after cardioneuroablation for vasovagal syncope: a systematic review and meta-analysis

Repolarization abnormalities at admission predict 30-day outcome in COVID-19.

Repeating non-invasive risk stratification tests improves the prediction of outcomes of ICD patients in the EUTrigTreat study.

QT correction and predictive value of QTc in atrial fibrillation

ESC 365 is supported by